{
    "clinical_study": {
        "@rank": "146189", 
        "acronym": "ARTERIA", 
        "arm_group": {
            "arm_group_label": "ST-elevation acute coronary syndrome", 
            "description": "ARTERY is a prospective, multicenter, which will include patients admitted with the diagnosis of ST-elevation acute coronary syndrome and thrombus aspiration is performed during primary angioplasty"
        }, 
        "brief_summary": {
            "textblock": "The prognostic value of inflammatory markers in acute coronary syndrome has been extensively\n      demonstrated, however it is still unknown whether there is an association between\n      circulating and local (thrombus) inflammatory molecules, and the subset of molecules that\n      provide better prognostic information in patients with ST-elevation acute coronary syndrome."
        }, 
        "brief_title": "inflAmmatory maRkers in Blood and Thrombus Aspirated From Patients With acutE myocaRdial Infarction With St-segment elevAtion", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Patients Admitted With the Diagnosis of ST-elevation Acute Coronary Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Myocardial Infarction", 
                "Acute Coronary Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  They include patients of both sexes, without limits of age, with a diagnosis of STEMI\n             within 12 hours after the beginning of symptoms. ST-elevation myocardial infarction\n             was defined in the presence of symptoms consistent, persistent elevation (> 20 min)\n             ST segment \u2265 1 mm in at least two contiguous leads or in the presence of left bundle\n             branch block presumably new onset and cardiac troponin I elevation\n\n        Exclusion Criteria:\n\n          -  Injury significant common core of left coronary artery (stenosis greater than or\n             equal to 50% of the vessel lumen).\n\n          -  Pre-Fibrinolysis percutaneous coronary intervention.\n\n          -  Previous coronary bypass surgery.\n\n          -  Thyrotoxicosis.\n\n          -  Having an inflammatory systemic or local inflammatory process.\n\n          -  Malignant neoplasm.\n\n          -  Any disease that seriously compromise the prognosis and / or systemic inflammatory\n             response generated.\n\n          -  No thrombotic material obtained in the thrombus or insufficient for performing\n             biochemical determinations."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Pilot, prospective cohort, which included all patients admitted with a diagnosis of\n        ST-elevation myocardial infarction and undergoing thrombus aspiration during a procedure\n        effective emerging percutaneous coronary revascularization."
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 22, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01757886", 
            "org_study_id": "ARTERIA-2012", 
            "secondary_id": "ARTERIA-2012"
        }, 
        "intervention": {
            "arm_group_label": "ST-elevation acute coronary syndrome", 
            "intervention_name": "Biomarkers to analyze both intracoronary thrombi as blood", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Myocardial infarction, Inflammation, Thrombus, Coronary angioplasty.", 
        "lastchanged_date": "December 22, 2012", 
        "location": [
            {
                "contact": {
                    "email": "adrvdg@hotmail.com", 
                    "last_name": "Alberto Dominguez-Rodriguez, MD, PhD", 
                    "phone": "+34 922 679040"
                }, 
                "facility": {
                    "address": {
                        "city": "La Laguna", 
                        "country": "Spain", 
                        "state": "Santa Cruz de Tenerife", 
                        "zip": "E-38320"
                    }, 
                    "name": "Hospital Universitario de Canarias"
                }, 
                "investigator": {
                    "last_name": "Alberto Dominguez-Rodriguez, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "adrvdg@hotmail.com", 
                    "last_name": "Alberto Dominguez-Rodriguez, MD, PhD", 
                    "phone": "+34 922679040"
                }, 
                "facility": {
                    "address": {
                        "city": "La Laguna", 
                        "country": "Spain", 
                        "state": "Santa Cruz de Tenerife", 
                        "zip": "E-38320"
                    }, 
                    "name": "Hospital Universitario de Canarias"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "adrvdg@hotmail.com", 
                    "last_name": "Alberto Dominguez-Rodriguez, MD, PhD", 
                    "phone": "+34 922 679040"
                }, 
                "facility": {
                    "address": {
                        "city": "La Laguna", 
                        "country": "Spain", 
                        "state": "Tenerife", 
                        "zip": "38320"
                    }, 
                    "name": "Hospital Universitario de Canarias"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "adrvdg@hotmail.com", 
            "last_name": "Alberto Dominguez-Rodriguez, MD, PhD", 
            "phone": "+34 922 679040"
        }, 
        "overall_official": {
            "affiliation": "Hospital Universitario de Canarias", 
            "last_name": "Alberto Dominguez-Rodriguez, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The primary objective of the study is to find out whether there is an association between certain inflammatory markers in blood and intracoronary thrombus and whether these markers are associated with the composite of all-cause mortality", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01757886"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Fundaci\u00f3n Canaria Rafael Clavijo para la Investigaci\u00f3n Biom\u00e9dica", 
            "investigator_full_name": "Enrique Quintero", 
            "investigator_title": "Alberto Dominguez Rodriguez", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Fundaci\u00f3n Canaria Rafael Clavijo para la Investigaci\u00f3n Biom\u00e9dica", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fundaci\u00f3n Canaria Rafael Clavijo para la Investigaci\u00f3n Biom\u00e9dica", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "12 Months", 
        "verification_date": "December 2012"
    }
}